Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kolon Tissuegene, Inc.

Clinical trials sponsored by Kolon Tissuegene, Inc., explained in plain language.

Kolon TissueGene, Inc. 950160 KOSDAQ

A biopharmaceutical company developing cell and gene therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

Could a single injection rebuild knees? phase 3 trial underway

Disease control Ongoing

This Phase 3 trial tests a single injection of TG-C, a cell-based treatment, in 535 people with moderate knee osteoarthritis. The goal is to see if it reduces pain and improves knee function compared to a placebo injection. Participants are followed for two years to check safety …

Phase: PHASE3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC